The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111343088 11134308 8 F 20150323 20160817 20150525 20160822 EXP CA-ROCHE-1581598 ROCHE 12.34 YR F Y 57.00000 KG 20160822 CN CA CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111343088 11134308 1 PS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 375 MG SOLUTION FOR INJECTION QOW
111343088 11134308 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 SOLUTION FOR INJECTION
111343088 11134308 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 SOLUTION FOR INJECTION
111343088 11134308 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 SOLUTION FOR INJECTION
111343088 11134308 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 SOLUTION FOR INJECTION
111343088 11134308 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 SOLUTION FOR INJECTION
111343088 11134308 7 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 SOLUTION FOR INJECTION
111343088 11134308 8 SS XOLAIR OMALIZUMAB 1 Subcutaneous U S0062,S0062,S0066B,S0001E,S0068D 103976 SOLUTION FOR INJECTION
111343088 11134308 9 C ASMANEX MOMETASONE FUROATE 1 Unknown U 0
111343088 11134308 10 C SINGULAIR MONTELUKAST SODIUM 1 Unknown U 0
111343088 11134308 11 C CLARITIN LORATADINE 1 Unknown U 0
111343088 11134308 12 C BRICANYL TERBUTALINE SULFATE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111343088 11134308 1 Asthma
111343088 11134308 9 Product used for unknown indication
111343088 11134308 10 Product used for unknown indication
111343088 11134308 11 Product used for unknown indication
111343088 11134308 12 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
111343088 11134308 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
111343088 11134308 Asthma
111343088 11134308 Body temperature decreased
111343088 11134308 Cough
111343088 11134308 Food allergy
111343088 11134308 Gastric disorder
111343088 11134308 Gastrooesophageal reflux disease
111343088 11134308 Headache
111343088 11134308 Heart rate increased
111343088 11134308 Hypersensitivity
111343088 11134308 Oropharyngeal pain
111343088 11134308 Pneumonia
111343088 11134308 Respiratory rate increased
111343088 11134308 Urticaria
111343088 11134308 Weight increased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111343088 11134308 1 20131210 0
111343088 11134308 2 20150407 0
111343088 11134308 3 20160310 0
111343088 11134308 4 20160324 0
111343088 11134308 5 20160427 0
111343088 11134308 6 20160602 0
111343088 11134308 7 20160804 0
111343088 11134308 8 20160817 0